Anti-HIV passive immunization with human neutralizing monoclonal antibodies (nmAbs) has made exciting gains: (i) identification of the HIV envelope V2 apex as a new in vivo protective epitope, (ii) a novel clade C SHIV for challenge studies, and (iii) a highly protective, trispecific nmAb. Potent, broad-spectrum protection by nmAbs holds promise.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701852 | PMC |
| http://dx.doi.org/10.1016/j.tim.2017.10.006 | DOI Listing |
Publication Analysis
Top Keywords
anti-hiv passive
8
passive immunization
8
immunization weapons
4
weapons arsenal
4
arsenal anti-hiv
4
immunization human
4
human neutralizing
4
neutralizing monoclonal
4
monoclonal antibodies
4
antibodies nmabs
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!